These effects were completely reversed in cells transiently transfected with a dominant negative FXR (FXR-DN) plasmid, supporting the direct involvement of this nuclear receptor in affecting leptin signaling in breast cancer cells (Fig. 2d). This evidence concerns the gene NR1H4 and breast carcinoma.